8-K current report · filed Nov 4, 2026

Labcorp (LH) 8-K Current Report: November 4, 2026

Item 7.01Item EX-99.1LH overview

Short answer

Labcorp (LH) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CFO Julia Wang scheduled to speak at UBS Global Healthcare Conference on November 10, 2026.

Labcorp 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • CFO Julia Wang scheduled to speak at UBS Global Healthcare Conference on November 10, 2026
  • Investor webcast at 8:45 a.m. ET, with replay available for 180 days
  • Potential venue for updated strategic, operating, or financial commentary on Labcorp

Item EX-99.1 · Exhibit EX-99.1

  • CFO Julia Wang scheduled to speak November 10 at the UBS Global Healthcare Conference
  • Fireside chat webcast may provide updates on strategy, operating trends and capital allocation
  • Labcorp serves approximately 100 countries with nearly 71,000 employees
  • Company performed more than 750 million patient tests and supported over 85% of FDA-approved drugs in 2025

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Labcorp 8-K filings

Get the next LH 8-K as it lands

Follow LH for push alerts, or ask the research agent what this filing means.